Jiangsu Eastern Shenghong (000301.SZ) traded flat 0 % during a 24 hours period ending at 04:07 PM Central Europe on Monday 26th. One Jiangsu Eastern Shenghong stock can currently be bought for about CNY 12.06 on popular exchanges. Current supply of Jiangsu Eastern Shenghong stocks is 6.6 bn. Jiangsu Eastern Shenghong has a current market capitalization of CNY 78.6 bn and approximately CNY 208.2 mn worth of Jiangsu Eastern Shenghong was traded on exchanges in the last 24 hours. Since last month end, Jiangsu Eastern Shenghong has traded -11 % down. Simple moving average of last 200 days is at CNY 12.62. The highest price of past 52 weeks was recorded at CNY 15.08 on 09/03/2026. 52 weeks low was at CNY 9 on 10/29/2025.
Here is how related stocks have performed in the past 24 hours:
Inner Mongolia Baotou Ste (600010.SS) traded flat 0 % and now trades at CNY 2.08. Inner Mongolia Baotou Ste has a market capitalisation of CNY 93.6 bn. Current price/earnings ratio for Inner Mongolia Baotou Ste is 184.82. On October 23, 2026, financing activity across the Chinese market remained robust, with a significant number of shares receiving institutional purchases. While the report lists a range of companies that attracted sizeable financing, none of the disclosed entries pertains to INNER MONGOLIA BAOTOU STE. Consequently, there is no direct evidence of financing or trading activity for this company within the provided data. The coverage focuses on broader market trends, noting that investors continue to seek opportunities in various sectors, and highlights the prominence of other firms in receiving financing. No specific information regarding price movements or investment decisions for INNER MONGOLIA BAOTOU STE is available in the excerpts supplied.
Yantai Jereh Oilfield (002353.SZ) traded flat 0 % and now trades at CNY 91.2. Current market capitalisation for Yantai Jereh Oilfield is CNY 93.6 bn. Yantai Jereh Oilfield has a current price to earnings ratio of 33.6. During the week of October 19–23, the Shanghai Composite fell modestly, while the Shenzhen Composite and ChiNext indices experienced larger declines. Analysts noted that capital flowed out of the power‑equipment sector, alongside significant withdrawals from the pharmaceutical‑biotech, telecommunications, and metal‑mining industries. In contrast, the beauty‑care, household‑appliances, petroleum‑chemical, and machinery sectors attracted net inflows, with the beauty‑care segment receiving the largest purchase volume among the primary industries. Several individual stocks attracted substantial inflows, including several technology and precision‑engineering firms, while the most heavily sold shares included major battery‑manufacturer and electronics companies. Three new listings appeared on the main market during the week, all of which saw strong first‑day gains. Overall, the market displayed a mix of sector‑specific outflows and targeted inflows, with broader commentary suggesting a cautious yet potentially opportunistic stance for investors.
Skyverse (688361.SS) traded flat 0 % and now trades at CNY 245. Current market capitalisation for Skyverse is CNY 91 bn.
Range Intelligent Computi (300442.SZ) traded flat 0 % and now trades at CNY 57.48. Range Intelligent Computi has a market capitalisation of CNY 93.8 bn. Range Intelligent Computi has a current price to earnings ratio of 17.49. RANGE INTELLIGENT COMPUTI reported strong performance in the first three quarters of 2026, with revenue nearly matching the previous year’s total and operating cash flow showing a marked increase. The company’s focus on AIDC computing business has continued to drive growth, and a recent capital increase of 4 billion yuan was directed toward AI project development. A wholly‑owned subsidiary expanded its registered capital, bringing in a new investment partner that will hold a substantial minority stake while the parent’s ownership remains majority. The transaction is described as reinforcing the company’s long‑term strategy and ensuring continued financial support for the expansion of domestic AIDC computing services, without altering the consolidated reporting structure or negatively impacting current operations.
Sichuan Kelun-biotech Biop-h (6990.HK) traded up 2.81 % and now trades at HKD 480.2. Sichuan Kelun-biotech Biop-h has a market capitalisation of HKD 110.1 bn. Sichuan Kelun-biotech Biop-h has a current price to earnings ratio of 608.27. Sichuan Kelun‑Biotech Biopharmaceutical Co., Ltd. reported that its key antibody‑drug conjugate, sacituzumab tirutocan (SKB264), has achieved significant clinical milestones in two phase‑III studies presented at the 2026 European Society for Medical Oncology Congress. In the OptiTROP‑Lung04 study, sac‑TMT monotherapy showed a meaningful extension of overall survival and a marked reduction in the risk of death compared with platinum‑based chemotherapy in patients with EGFR‑mutant non‑small cell lung cancer who had progressed after EGFR‑tyrosine kinase inhibitor therapy. The OptiTROP‑Lung06 study demonstrated that adding sac‑TMT to the immune checkpoint inhibitor pembrolizumab substantially improved progression‑free survival and produced durable responses in patients with driver‑gene‑negative, PD‑L1‑negative advanced non‑small cell lung cancer, with a safety profile comparable to the individual agents. These findings reinforce the company’s position in developing TROP2‑targeted therapies for solid tumours and support ongoing regulatory and commercial developments in China and abroad.
About Jiangsu Eastern Shenghong
Jiangsu Eastern Shenghong Co., Ltd. is a material sector company headquartered in Suzhou, China that specializes in manufacturing and distributing textile products. The company produces polyester filament and other chemical fiber products. Additionally, Jiangsu Eastern Shenghong engages in electricity-heat generation and petrochemical businesses. Their official website is accessible under www.jsessh.com and they are listed on the Shenzhen Stock Exchange.